The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
Citation:
Molecular Cancer
2025
24:134

Prepay
Funding for your BMC & SpringerOpen article processing charges (APCs)
As an affiliated author, your APC could be funded by our institution’s BMC and SpringerOpen membership fund.
Please follow the submission guidelines to benefit from this membership.
Page 1 of 38